// App-Quantinova.ai

Mo1788 : Vasoactive Intestinal Polypeptide and Neuronal Nitric Oxide Synthase Act via Parallel Pathways As Mediators of GLP-2 Anti-Inflammatory Activity

Researchers

Presenter

  • Elaine de Heuvel

Principal Investigators

  • James Waschek

  • David L. Sigalet

Medical Centers

  • Psychiatry, UCLA, Los Angeles, CA

  • Surgery Pediatric, Univ Calgary, Calgary, AB, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • Myeloperoxidase

  • Caspase 3

  • Interleukin 1

  • Interleukin 10

  • Tumor necrosis factor

  • Vasoactive intestinal polypeptide

  • Glucagon-like peptide-2

Drug/Treatment

  • Nitric oxide

  • Intranasal glucagon

  • Interleukin-10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved